secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001193805-25-000757
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic prices $65M underwritten offering of pre-funded warrants and Series A/B warrants
--------------------------------------------------------------------------------

- Offering of 86.7M pre-funded warrants plus Series A & B warrants at $0.7499 per unit; proceeds ~$65M.
- Series A warrants ($0.75 exercise) expire Dec 31, 2025; Series B warrants ($0.75) exercisable from Oct 2025 or upon VWAP ≥$1.25.
- Potential additional $130M gross proceeds if Series A and B warrants fully exercised for cash.
- Leerink Partners sole bookrunner; B. Riley Securities and Brookline Capital co-managers; close expected June 3, 2025.
- Proceeds to fund clinical trials and operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380525000757/0001193805-25-000757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380525000757/e664551_8k-immunicpricing.htm
  HTML page:      https://secwatch.observer/filing/0001193805-25-000757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer